Bhubaneswar, July 19 -- https://images.odishatv.in/uploadimage/library/16_9/16_9_0/recent_photo_1752916239.webp
In a landmark scientific development, the Regional Medical Research Centre (RMRC), Bhubaneswar, has successfully developed an advanced malaria vaccine while simultaneously opening up tech transfer for the vaccine.
According to reports shared by RMRC on its X handle, the recombinant, chimeric multi-stage malaria vaccine is named AdFalciVax and marks a major step forward in India's fight against Plasmodium falciparum, the deadliest malaria parasite infecting humans.
Unlike existing vaccines currently available in the market, AdFalciVax offers dual-stage protection by preventing both human infection and community-level transmissio...